Pharma Stocks Surge as Trump Tariff Fears Ease

Indian pharmaceutical stocks experienced a significant rally following the easing of concerns surrounding potential US tariffs. The sector, initially jittery after President Trump's announcement of reciprocal tariffs on trading partners, saw a surge in investor confidence as the pharma industry remained largely untouched by the initial measures. Key highlights of the pharma stock rally include: Top Gainers:

s shares led the pack, climbing nearly 5% to trade at Rs 453 apiece. Laurus Labs and Cipla shares followed closely, each rising over 4%. ma, Aurobindo Pharma, and Biocon also saw substantial gains, jumping over 3.7% each. Widespread Gains: !Lupin and s Life shares increased by nearly 3%. Natco Pharma, Dr. Reddy’s Labs, Gland Pharma, and Torrent Pharma all saw gains of nearly 2%. Mankind Pharma, Abbott India, and Zydus Lifesciences experienced gains of over 1%.